4,516
Participants
Start Date
January 25, 2016
Primary Completion Date
October 3, 2019
Study Completion Date
September 3, 2020
Accelerated, combined biomarker rule-out strategy for MI
Blood sample is acquired while the patient is in the ambulance. This is brought to hospital and handed over to the laboratory personnel for acute analysis for copeptin level. At arrival to hospital, a second blood sample is acquired and analyzed for high-sensitive cardiac troponin-T(hs-cTnT). Answers of these analyzes are in-hand with-in 60 minutes. If copeptin in the pre-hospital blood sample is \<9,8 pmol/L (95% percentile) AND hs-cTnT in the in-hospital blood sample is \<14ng/L (99% percentile), then myocardial infarction can be ruled out, and depending of clinical presentation, the patient can be discharged.
Department of Cardiology, Aarhus University Hospital, Aarhus
Department of Internal Medicine, Horsens Regional Hospital, Horsens
Department of Cardiology, Viborg Regional Hospital, Viborg
Aarhus University Hospital Skejby
OTHER